The efficient transformation of D-glucal to (2R)-hydroxymethyldihydropyridinone 5 in seven steps and 35 % overall yield is reported. Dihydropyridone 5 constitutes a versatile chiral building block for the synthesis of various piperidine alkaloids. In this regard, 5 was converted to piperidinol 13 and piperidinone 15, that may be further elaborated for the syntheses of (+)-desoxoprosophylline (1) and deoxymannojirimycin (3) or D-mannolactam (4), respectively.
Introduction
Piperidine alkaloids comprise a large family of compounds that exhibit a large spectrum of biological activities of medicinal interest. In particular, alkaloid lipids such as (+)-desoxoprosophylline (1, Figure 1) [1] display significant anesthetic, analgesic and antibiotic activities [2] [3] [4] , while their corresponding iminosugars -exemplified by N-butyl-1-deoxynojirimycin (NB-DNJ, 2) which was recently approved for the treatment of Gaucher disease [5] -constitute promising leads for the development of immunosuppressive [6] , antiviral [7] , antidiabetic [8] and antitumour agents [9] . In addition, deoxymannojirimycin (3) and D-mannolactam (4, Figure 1 ) have also shown to inhibit various enzymes that participate in the binding and processing of diverse glycoproteins, underlying their possible therapeutic values [10] [11] [12] . 
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As a result intense research efforts have been devoted to the development of methodologies and synthetic strategies for the efficient preparation of these compounds and derivatives. Most of these methods utilize sugars or amino acids as their chiral pool synthons [13] [14] [15] [16] [17] [18] [19] and suffer from a lack of selectivity and applicability to diverse compounds. On the other hand, the optically active 1,6-dihydro-2H-pyridin-3-ones represent flexible building blocks for the efficient access to diverse multifunctionalized bioactive indolizines, quinolizidines and piperidine alkaloids [20] . Recently, we reported the preparation of (2S)-hydroxymethyldihydropyridinone, [21] a chiral key intermediate for the synthesis of various piperidine alkaloids such as (-)-desoxoprosophylline, allonojirimycin and indolizidine alkaloids (e.g. swainsonine). The common structural feature of all the aforementioned molecules is the (S)-configuration at C-2. Herein we present an efficient and highly enantioselective route to its (R)−enantiomer 5 starting from the commercially available D-glucal. This molecule represents a key intermediate for the synthesis of broad variety natural and unnatural piperidine alkaloids and/or iminosugars displaying an (R)-configuration at C-2.
Results and Discussion
The key step for the implementation of the proposed synthetic sequence is the synthesis of chiral (R)-N-[2-(tert-butyldiphenylsilyloxy)-1-furan-2-yl-ethyl]-4-methylbenzenesulfonamide (10) , since all final products retain that stereochemistry. Commercially available D-glucal was used as strarting material for the synthesis of this intermediate. More specifically, D-glucal was reacted with HgSO 4 (as a solution in 0.002 M H 2 SO 4 ) and subsequently its primary hydroxy group was protected with TBDPSCl to provide the 2-furyl glycol (+)−6, according to a literature procedure reported by Hauser et al. (Scheme 1) [22] .
The stereochemistry of compound 6 was efficiently inverted using the Mitsunobu protocol (DEAD, Ph 3 P, benzoic acid) affording the (S)-ethyl-2-(tert-butyldiphenylsilanyloxy)-1-furan-2-yl-benzoate 7, which was further saponified to afford (S)-1-furan-2-yl-ethanol 8. The displacement of the secondary hydroxy group with azide with inversion of configuration was performed in high enantiomeric excess (>98%) on treating 8 with DBU in toluene and DPPA. The enantiomeric excess was determined by hydrogenating compound 9 over 10% Pd/C (4 mg) under 1 bar pressure for 40 min [23] The diastereomeric purity of the product was revealed by 1 H-NMR and HPLC, since the presence of the other diastereoisomer was not detected, while the stereochemistry of the newly formed stereocenter was determined by 2D-NOESY spectroscopic analysis (the absolute configuration at C-2 derives from the starting material). Thus, the clear strong cross peak observed between the protons on C-2 and C-6 is indicative of their cis pseudo-diaxial conformation ( Figure 2 ). Furthermore, the observed NOE between the aromatic protons of the tosyl group and the protons of tert-butyldiphenylsilanyloxymethyl group confirmed this configuration. Finally, the observed optical rotation value for 
Conclusions
In summary, we have demonstrated a concise synthetic route to (2R)-hydroxymethyldihydropyridone 5, a chiral key intermediate useful in the synthesis of a variety of naturally occurring bioactive piperidine alkaloids, such as (+)-desoxoprosophylline, deoxymannojirimycin and D-mannolactam.
Experimental
General Air-and /or moisture sensitive reactions were carried out under an argon atmosphere in flamedried glassware. Solvents were distilled from the appropriate drying agents prior to use. All starting materials were purchased from Aldrich (analytical reagent grades) and used without further
+28.7, c 2.03, MeOH) was prepared according to a literature procedure [22] . All reactions were monitored by thin-layer chromatography using TLC sheets coated with silica gel 60 F 254 (Merck); spots were visualized with UV light or/and an alcohol solution of anisaldehyde. Products were purified by flash chromatography on Merck silica gel 60 (230-400 mesh ASTM 
(R)-(2-Azido-2-furan-2-yl-ethoxy)-tert-butyldiphenylsilane (9).
To an ice-cold solution of (2S)-2-furyl glycol 8 (0.4 g, 1.09 mmol) and diphenylphosphoryl azide (0.23 mL, 1.09 mmol) in dry toluene (3 mL) was added DBU (0.16 mL, 1.09 mmol) in small portions and the resulting mixture stirred for 2 h at 0 °C. The mixture was allowed to reach the room temperature, stirred for an additional 20 h and then washed successively with H 2 O (2×3 mL) and 5% HCl (2 mL), dried over MgSO 4 (10) . Azide 9 (0.4 g, 1.02 mmol) was dissolved in EtOAc (10 mL) and hydrogenated over 10% Pd/C (0.04 g) under 1 bar pressure for 40 min. The reaction mixture was filtered over Celite ® and concentrated in vacuo.
(R)-N-[2-(tert-Butyldiphenylsilyloxy)-1-furan-2-yl-ethyl]-4-methylbenzenesulfonamide
The residue was dissolved in CH 2 Cl 2 (3 mL) and Et 3 N (0.2 mL, 1.5 mmol) was added. The resulting solution was cooled to 0 °C and p-TsCl (0.28 g, 1.5 mmol) was added portionwise under stirring. The reaction mixture was allowed to reach r.t., stirred for an additional 3 h. and then extracted successively with sat. aq. NaHCO 3 (2 mL) and brine, dried over MgSO 4 and concentrated to dryness. The crude product was chromatographed (hexane/EtOAc 4:1, R f = 0.4) yielding 0. (14) . To an ice cold solution of compound 5 (0.1 g, 0.188 mmol) in acetone (1.3 mL) at -10 °C, was added dropwise Jones reagent (0.1 mL). After being stirred for 20 min, the solid inorganic by products were eliminated by decantation and the liquid layer was concentrated to a residue that was partitioned in EtOAc (4 mL) and H 2 O (2 mL). The organic layer was separated, washed with brine, dried over MgSO 4 , and evaporated. The residue was crystallized from cold 
(2R,6S)-2-(tert-Butyldiphenylsilyloxyphenyl)-6-methoxy-1-(toluene-4-sulfonyl)-1,6-dihydropyridin-3-(2H)-one (11)
.(6R)-6-(tert-Butyldiphenylsilyloxymethyl)-6-methoxy-1-(toluene-4-sulfonyl)-1,6-dihydropyridine-2,5- dione
